FAM107A Human (S)-nicotine decreases expression ISO Fam107a (Mus musculus) 6480464 Nicotine results in decreased expression of FAM107A mRNA CTD PMID:21955143 FAM107A Human 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression EXP 6480464 o and p'-DDT results in decreased expression of FAM107A mRNA CTD PMID:19371625 FAM107A Human 1,1-dichloroethene decreases expression ISO Fam107a (Mus musculus) 6480464 vinylidene chloride results in decreased expression of FAM107A mRNA CTD PMID:26682919 FAM107A Human 1,2-dichloroethane decreases expression ISO Fam107a (Mus musculus) 6480464 ethylene dichloride results in decreased expression of FAM107A mRNA CTD PMID:28960355 FAM107A Human 17alpha-ethynylestradiol decreases expression ISO Fam107a (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of FAM107A mRNA CTD PMID:29097150 FAM107A Human 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of FAM107A mRNA CTD PMID:23019147 FAM107A Human 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of FAM107A mRNA CTD PMID:29581250 FAM107A Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Fam107a (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of FAM107A mRNA CTD PMID:19770486 FAM107A Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Fam107a (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of FAM107A mRNA CTD PMID:32109520 FAM107A Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Fam107a (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FAM107A mRNA CTD PMID:25975270 FAM107A Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Fam107a (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of FAM107A mRNA CTD PMID:21570461 and PMID:24680724 FAM107A Human 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Fam107a (Mus musculus) 6480464 3 more ... CTD PMID:19467301 FAM107A Human 3,4-methylenedioxymethamphetamine increases expression ISO Fam107a (Rattus norvegicus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of FAM107A mRNA CTD PMID:30071829 FAM107A Human 4,4'-sulfonyldiphenol increases expression ISO Fam107a (Mus musculus) 6480464 bisphenol S results in increased expression of FAM107A mRNA CTD PMID:30951980 FAM107A Human 4,4'-sulfonyldiphenol decreases methylation EXP 6480464 bisphenol S results in decreased methylation of FAM107A gene CTD PMID:31601247 FAM107A Human 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol S co-treated with Fulvestrant] results in increased methylation of FAM107A gene CTD PMID:31601247 FAM107A Human 5-aza-2'-deoxycytidine affects expression EXP 6480464 Decitabine affects the expression of FAM107A mRNA CTD PMID:23300844 FAM107A Human 6-propyl-2-thiouracil decreases expression ISO Fam107a (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of FAM107A mRNA CTD PMID:24780913 and PMID:25825206 FAM107A Human aflatoxin B1 decreases expression ISO Fam107a (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of FAM107A mRNA CTD PMID:19770486 FAM107A Human aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of FAM107A gene CTD PMID:27153756 FAM107A Human all-trans-retinoic acid multiple interactions ISO Fam107a (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FAM107A mRNA CTD PMID:36189433 FAM107A Human all-trans-retinoic acid increases expression ISO Fam107a (Mus musculus) 6480464 Tretinoin results in increased expression of FAM107A mRNA CTD PMID:36189433 FAM107A Human arsane decreases expression ISO Fam107a (Mus musculus) 6480464 Arsenic results in decreased expression of FAM107A mRNA CTD PMID:19654921 FAM107A Human arsenic atom decreases expression ISO Fam107a (Mus musculus) 6480464 Arsenic results in decreased expression of FAM107A mRNA CTD PMID:19654921 FAM107A Human arsenite(3-) increases methylation EXP 6480464 arsenite results in increased methylation of FAM107A promoter CTD PMID:23974009 FAM107A Human arsenous acid increases expression ISO Fam107a (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of FAM107A mRNA CTD PMID:35676786 FAM107A Human benzo[a]pyrene decreases expression ISO Fam107a (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of FAM107A mRNA CTD PMID:19770486 FAM107A Human benzo[a]pyrene multiple interactions ISO Fam107a (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FAM107A mRNA CTD PMID:27858113 FAM107A Human benzo[a]pyrene increases expression ISO Fam107a (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of FAM107A mRNA CTD PMID:21569818 FAM107A Human benzo[b]fluoranthene multiple interactions ISO Fam107a (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FAM107A mRNA CTD PMID:27858113 FAM107A Human beta-hexachlorocyclohexane decreases expression ISO Fam107a (Mus musculus) 6480464 beta-hexachlorocyclohexane results in decreased expression of FAM107A mRNA CTD PMID:25270620 FAM107A Human bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of FAM107A mRNA CTD PMID:31163220 FAM107A Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FAM107A mRNA CTD PMID:19371625 FAM107A Human bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of FAM107A gene CTD PMID:31601247 FAM107A Human bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of FAM107A gene CTD PMID:31601247 FAM107A Human bisphenol A increases expression ISO Fam107a (Mus musculus) 6480464 bisphenol A results in increased expression of FAM107A mRNA CTD PMID:30951980 FAM107A Human bisphenol A decreases expression ISO Fam107a (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of FAM107A mRNA CTD PMID:25181051 more ... FAM107A Human bisphenol F affects expression ISO Fam107a (Mus musculus) 6480464 bisphenol F affects the expression of FAM107A mRNA CTD PMID:30951980 FAM107A Human buta-1,3-diene increases expression ISO Fam107a (Mus musculus) 6480464 1 and 3-butadiene results in increased expression of FAM107A mRNA CTD PMID:29038090 FAM107A Human butanal increases expression EXP 6480464 butyraldehyde results in increased expression of FAM107A mRNA CTD PMID:26079696 FAM107A Human cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of FAM107A mRNA CTD PMID:38382870 FAM107A Human carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of FAM107A mRNA CTD PMID:25979313 FAM107A Human carbon nanotube affects expression ISO Fam107a (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of FAM107A mRNA CTD PMID:25554681 FAM107A Human carbon nanotube increases expression ISO Fam107a (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of FAM107A mRNA CTD PMID:25554681 FAM107A Human chloroprene increases expression ISO Fam107a (Rattus norvegicus) 6480464 Chloroprene results in increased expression of FAM107A mRNA CTD PMID:23125180 FAM107A Human chloroprene increases expression ISO Fam107a (Mus musculus) 6480464 Chloroprene results in increased expression of FAM107A mRNA CTD PMID:23125180 FAM107A Human chrysene multiple interactions ISO Fam107a (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FAM107A mRNA CTD PMID:27858113 FAM107A Human cisplatin affects expression EXP 6480464 Cisplatin affects the expression of FAM107A mRNA CTD PMID:23300844 FAM107A Human clofibrate decreases expression ISO Fam107a (Mus musculus) 6480464 Clofibrate results in decreased expression of FAM107A mRNA CTD PMID:25270620 FAM107A Human cobalt dichloride decreases expression ISO Fam107a (Rattus norvegicus) 6480464 cobaltous chloride results in decreased expression of FAM107A mRNA CTD PMID:24386269 FAM107A Human copper atom increases expression ISO Fam107a (Rattus norvegicus) 6480464 Copper results in increased expression of FAM107A mRNA CTD PMID:30556269 FAM107A Human copper(0) increases expression ISO Fam107a (Rattus norvegicus) 6480464 Copper results in increased expression of FAM107A mRNA CTD PMID:30556269 FAM107A Human crocidolite asbestos decreases expression ISO Fam107a (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of FAM107A mRNA CTD PMID:29279043 FAM107A Human Cuprizon decreases expression ISO Fam107a (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of FAM107A mRNA CTD PMID:26577399 FAM107A Human cyclosporin A decreases expression ISO Fam107a (Mus musculus) 6480464 Cyclosporine results in decreased expression of FAM107A mRNA CTD PMID:19770486 FAM107A Human dexamethasone increases expression ISO Fam107a (Mus musculus) 6480464 Dexamethasone results in increased expression of FAM107A mRNA CTD PMID:23946490 FAM107A Human dexamethasone multiple interactions ISO Fam107a (Mus musculus) 6480464 Valproic Acid inhibits the reaction [Dexamethasone results in increased expression of FAM107A mRNA] CTD PMID:23946490 FAM107A Human diarsenic trioxide increases expression ISO Fam107a (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of FAM107A mRNA CTD PMID:35676786 FAM107A Human dibenz[a,h]anthracene increases expression ISO Fam107a (Mus musculus) 6480464 1 more ... CTD PMID:26377693 FAM107A Human dibutyl phthalate decreases expression ISO Fam107a (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of FAM107A mRNA CTD PMID:21266533 FAM107A Human dichloroacetic acid decreases expression ISO Fam107a (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of FAM107A mRNA CTD PMID:28962523 FAM107A Human diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of FAM107A mRNA CTD PMID:19371625 FAM107A Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 FAM107A Human doxorubicin multiple interactions ISO Fam107a (Mus musculus) 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of FAM107A mRNA CTD PMID:21040762 FAM107A Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of FAM107A mRNA CTD PMID:29803840 FAM107A Human doxorubicin increases expression ISO Fam107a (Mus musculus) 6480464 Doxorubicin results in increased expression of FAM107A mRNA CTD PMID:21040762 and PMID:28608983 FAM107A Human elemental selenium increases expression EXP 6480464 Selenium results in increased expression of FAM107A mRNA CTD PMID:19244175 FAM107A Human Erionite decreases expression ISO Fam107a (Mus musculus) 6480464 erionite results in decreased expression of FAM107A mRNA CTD PMID:29279043 FAM107A Human ethanol increases expression ISO Fam107a (Mus musculus) 6480464 Ethanol results in increased expression of FAM107A mRNA CTD PMID:21955143 and PMID:30319688 FAM107A Human ethanol affects expression ISO Fam107a (Mus musculus) 6480464 Ethanol affects the expression of FAM107A mRNA CTD PMID:30319688 FAM107A Human ethanol affects splicing ISO Fam107a (Mus musculus) 6480464 Ethanol affects the splicing of FAM107A mRNA CTD PMID:30319688 FAM107A Human folic acid increases expression ISO Fam107a (Mus musculus) 6480464 Folic Acid results in increased expression of FAM107A mRNA CTD PMID:25629700 FAM107A Human fulvestrant multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of FAM107A gene and [bisphenol S co-treated with Fulvestrant] results in increased methylation of FAM107A gene CTD PMID:31601247 FAM107A Human genistein decreases expression EXP 6480464 Genistein results in decreased expression of FAM107A mRNA CTD PMID:19371625 FAM107A Human inulin multiple interactions ISO Fam107a (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FAM107A mRNA CTD PMID:36331819 FAM107A Human manganese atom decreases expression ISO Fam107a (Rattus norvegicus) 6480464 Manganese results in decreased expression of FAM107A mRNA CTD PMID:26745496 FAM107A Human manganese(0) decreases expression ISO Fam107a (Rattus norvegicus) 6480464 Manganese results in decreased expression of FAM107A mRNA CTD PMID:26745496 FAM107A Human manganese(II) chloride decreases expression ISO Fam107a (Rattus norvegicus) 6480464 manganese chloride results in decreased expression of FAM107A mRNA CTD PMID:26745496 FAM107A Human medroxyprogesterone acetate increases expression EXP 6480464 Medroxyprogesterone Acetate results in increased expression of FAM107A mRNA CTD PMID:20843944 FAM107A Human methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of FAM107A mRNA CTD PMID:28001369 FAM107A Human methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of FAM107A mRNA CTD PMID:34089799 FAM107A Human methylseleninic acid increases expression EXP 6480464 methylselenic acid results in increased expression of FAM107A mRNA CTD PMID:18548127 FAM107A Human mono(2-ethylhexyl) phthalate multiple interactions ISO Fam107a (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FAM107A mRNA CTD PMID:36189433 FAM107A Human morphine increases expression ISO Fam107a (Mus musculus) 6480464 Morphine results in increased expression of FAM107A mRNA CTD PMID:21955143 FAM107A Human nevirapine increases expression ISO Fam107a (Rattus norvegicus) 6480464 Nevirapine results in increased expression of FAM107A mRNA CTD PMID:23947594 FAM107A Human nicotine decreases expression ISO Fam107a (Mus musculus) 6480464 Nicotine results in decreased expression of FAM107A mRNA CTD PMID:21955143 FAM107A Human ozone multiple interactions ISO Fam107a (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FAM107A mRNA and [Air Pollutants results in increased abundance of Ozone] which affects the expression of FAM107A mRNA CTD PMID:34911549 FAM107A Human PCB138 decreases expression ISO Fam107a (Rattus norvegicus) 6480464 2 more ... CTD PMID:23829299 FAM107A Human perfluorohexanesulfonic acid decreases expression ISO Fam107a (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of FAM107A mRNA CTD PMID:37995155 FAM107A Human perfluorooctane-1-sulfonic acid multiple interactions ISO Fam107a (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FAM107A mRNA CTD PMID:36331819 FAM107A Human phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM107A mRNA CTD PMID:27188386 FAM107A Human poly(I:C) multiple interactions ISO Fam107a (Rattus norvegicus) 6480464 [Poly I-C co-treated with HU 211] results in decreased expression of FAM107A mRNA CTD PMID:26923065 FAM107A Human progesterone increases expression EXP 6480464 Progesterone results in increased expression of FAM107A mRNA CTD PMID:17404688 FAM107A Human resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of FAM107A mRNA CTD PMID:19371625 FAM107A Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 FAM107A Human selenium atom increases expression EXP 6480464 Selenium results in increased expression of FAM107A mRNA CTD PMID:19244175 FAM107A Human sodium arsenate increases expression ISO Fam107a (Mus musculus) 6480464 sodium arsenate results in increased expression of FAM107A mRNA CTD PMID:21795629 FAM107A Human tamoxifen increases expression ISO Fam107a (Mus musculus) 6480464 Tamoxifen results in increased expression of FAM107A mRNA CTD PMID:25123088 FAM107A Human tetrachloromethane increases expression ISO Fam107a (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of FAM107A mRNA CTD PMID:31919559 FAM107A Human tetraphene multiple interactions ISO Fam107a (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FAM107A mRNA CTD PMID:27858113 FAM107A Human titanium dioxide decreases expression ISO Fam107a (Mus musculus) 6480464 titanium dioxide results in decreased expression of FAM107A mRNA CTD PMID:19464567 FAM107A Human tremolite asbestos decreases expression ISO Fam107a (Mus musculus) 6480464 tremolite results in decreased expression of FAM107A mRNA CTD PMID:29279043 FAM107A Human trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of FAM107A mRNA CTD PMID:26272509 FAM107A Human trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM107A mRNA CTD PMID:27188386 FAM107A Human Triptolide decreases expression ISO Fam107a (Mus musculus) 6480464 triptolide results in decreased expression of FAM107A mRNA CTD PMID:32835833 FAM107A Human triptonide increases expression ISO Fam107a (Mus musculus) 6480464 triptonide results in increased expression of FAM107A mRNA CTD PMID:33045310 FAM107A Human valproic acid multiple interactions ISO Fam107a (Mus musculus) 6480464 Valproic Acid inhibits the reaction [Dexamethasone results in increased expression of FAM107A mRNA] CTD PMID:23946490 FAM107A Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM107A mRNA CTD PMID:27188386 FAM107A Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of FAM107A mRNA CTD PMID:26272509 FAM107A Human vitamin E increases expression EXP 6480464 Vitamin E results in increased expression of FAM107A mRNA CTD PMID:19244175 FAM107A Human vorinostat multiple interactions EXP 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM107A mRNA CTD PMID:27188386 FAM107A Human vorinostat decreases expression EXP 6480464 vorinostat results in decreased expression of FAM107A mRNA CTD PMID:26272509 FAM107A Human zearalenone decreases expression EXP 6480464 Zearalenone results in decreased expression of FAM107A mRNA CTD PMID:19371625 FAM107A Human zoledronic acid increases expression EXP 6480464 zoledronic acid results in increased expression of FAM107A mRNA CTD PMID:24714768